Overview A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) Status: RECRUITING Trial end date: 2025-11-30 Target enrollment: Participant gender: Summary This study will evaluate the effect and safety of 608 in patients with nr-axSpA.Phase: PHASE2 Details Lead Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.